UK WOMEN “UNDIAGNOSED AND UNDERTREATED” FOR HEART DISEASE

UK WOMEN “UNDIAGNOSED AND UNDERTREATED” FOR HEART DISEASE

7th October 2024

Lead author, Professor Vijay Kunadian, told the PA news agency: “Heart disease, in particular coronary artery disease, is the number one killer for women in the UK and worldwide.

“And yet, even to this day, we see that their symptoms are being ignored or (women are) told there is nothing wrong with them, or treated for something else, when all along they might be suffering from a heart problem.”

She said national databases are showing “year after year” that women are being undertreated and “unfortunately that leads to higher death rates following heart attacks.

“We can’t ignore that any more, it is about time that we do something about it”.

Lives are being lost because “if women received the correct treatment, then their lives could be saved”, Prof Kunadian said.

BCIS Secretariat, Millbrook Medical Conferences Ltd
Unit 8, Midland Court, Central Park, Lutterworth
Leicestershire LE17 4PN

BRITISH SOCIETY OF GASTROENTEROLOGY: ADDENDUM TO BSG/ESGE ENDOSCOPY IN PATIENTS ON ANTIPLATELET OR ANTICOAGULANT THERAPY GUIDELINE 2021

BRITISH SOCIETY OF GASTROENTEROLOGY: ADDENDUM TO BSG/ESGE ENDOSCOPY IN PATIENTS ON ANTIPLATELET OR ANTICOAGULANT THERAPY GUIDELINE 2021

11th June 2024

Dear BCIS Member,

We ask you to familiarise yourself with the statement from the British Society of Gastroenterology.

Thank you,

Prof Dave Hildick-Smith,  BCIS President

EOI: NICOR Left Atrial Appendage Domain Expert Group

EOI: NICOR Left Atrial Appendage Domain Expert Group

6th June 2024

Dear BCIS Member,

Expressions of interest are sought for new members of the NICOR Left Atrial Appendage Domain Expert Group. Members will work closely with the Clinical Lead, Dr Steve Murray to deliver the LAAO national registry and audit programme.

If you are interested in this role, please contact Dr Murray by e-mail at stephen.murray6@nhs.net

Thank you,

Prof Dan Blackman, BCIS Structural Working Group Lead

 

Radcliffe Cardiology’s Journal, ICR3, Latest Publication: Left Atrial Appendage Occlusion: British Cardiovascular Intervention Society and British Heart Rhythm Society Position Statement

Radcliffe Cardiology’s Journal, ICR3, Latest Publication: Left Atrial Appendage Occlusion: British Cardiovascular Intervention Society and British Heart Rhythm Society Position Statement

20th March 2024

The latest publication is now available.

Abstract

Percutaneous left atrial appendage occlusion aims to reduce the risk of stroke in patients with AF, particularly those who are not good candidates for systemic anticoagulation. The procedure has been studied in large international randomised trials and registries and was approved by the National Institute for Health and Care Excellence in 2014 and by NHS England in 2018. This position statement summarises the evidence for left atrial appendage occlusion and presents the current indications. The options and consensus on best practice for pre-procedure planning, undertaking a safe and effective implant and appropriate post-procedure management and follow-up are described. Standards regarding procedure volume for implant centres and physicians, the role of multidisciplinary teams and audits are highlighted.

Mayo Clinic Structural Intervention Fellowship Opportunity, One Year Fully Funded Starting 1 July 2024

Mayo Clinic Structural Intervention Fellowship Opportunity, One Year Fully Funded Starting 1 July 2024

2nd March 2024

An exciting opportunity has arisen for a suitably qualified UK trainee to undertake a 1 year fellowship in Structural Intervention at the Mayo Clinic.

The successful candidate would work with two other Structural Fellows in a department performing 580 TAVIs, 100 m-TEERS, 130 LAAOs, as well as TMVR, TTVR, and other innovative structural interventions. Approximately 100 PCI procedures would also be expected. Potential candidates must have obtained the USMLE examinations, parts 1-3, and must have completed training in coronary intervention.

Interested candidates should contact Prof. Rajiv Gulati, Director, cardiac catheterization laboratory, for further information gulati.rajiv@mayo.edu.

VOTE NOW: Global Cardiovascular Awards 2024

VOTE NOW: Global Cardiovascular Awards 2024

8th February 2024

Global Cardiovascular Awards 2024 are being held on Thursday 14 March 2024.

Have your chance to vote for the shortlisted teams that are being recognised for their efforts to provide comprehensive, multidisciplinary care to cardiovascular disease patients, and seeks to find the heart team with the greatest commitment to cross-disciplinary specialty in patients’ best interest.

Winner to be announced on the night.

EAPCI Hosting Centres 2024

EAPCI Hosting Centres 2024

8th November 2023

Dear Presidents of the National Societies or Working Groups of Interventional Cardiology,

In 2023 I have chaired the EAPCI grants training program committee. Under my lead and with the cooperation of the members of the committee and the EAPCI staff, our Association has obtained an unprecedented number of grants. Furthermore, we have paid particular attention to an equal distribution of the grants between genders and to favour candidates from Countries where the possibilities of getting access to training are more difficult, because it is our goal to facilitate high-level education to the grant winners to improve health care once they are back to their Country of origin.

In 2024 we will try to replicate the outstanding performance we delivered in 2023, with the added value of including many more centres of excellence where the award winners can train and develop their research projects.

For this reason, I am taking the liberty to writing to you to make sure that you are aware of the extraordinary opportunity that an EAPCI training grant represents for young interventionalists, and to ask you to promote this initiative of our European Association within your National Society.

The Centres of excellence can directly apply to appear in the list of EAPCI Hosting Centres 2024 by visiting our webpage here

With the best personal regards

Prof. Flavio L. Ribichini
Professor of Cardiovascular Medicine
University of Verona
Chairman of the EAPCI ESC Fellowship Committee

BHVS Annual Meeting: 10 Free Places Offered to Interventional Trainees

BHVS Annual Meeting: 10 Free Places Offered to Interventional Trainees

8th September 2023

The British Heart Valve Society (BHVS) is offering 10 free places for interventional trainees with an interest in structural and valve intervention at its Annual Meeting in October. The 10 free places are available on a first-come, first-serve basis.

The theme for the one-day meeting taking place on Friday 13 October at the Royal College of Physicians, London, is State-of-the-Art Management in Heart Valve Disease.

Session titles include:

  • SCTS: State-of-the-Art in Heart Valve Surgery
  • BISMICS: State-of-the-Art in Minimally Invasive Heart Valve Surgery
  • State-of-the-Art in Transcatheter Heart Valve Intervention
  • How Do We Achieve State-of-the-Art?
  • Best Abstract Awards
  • BHVS AGM

Click here to view the full programme and speaker line-up.

So, if you’re an interventional trainee with an interest in structural and valve intervention and would like a free place at the BHVS Annual Meeting, please email Richard Bazneh (admin@bhvs.org.uk) to express your interest.

TAVI and Structural Benchmarking Survey

TAVI and Structural Benchmarking Survey

6th July 2023

Dear Structural and TAVI centres,

We would greatly appreciate you taking a couple of minutes to fill in this 9 question short survey to help us understand the staffing you have around your TAVI and structural services you provide to patients. We are keen to have some numbers in order to support growing teams and help those who are currently developing business cases for growing teams. The data will be available for those looking to set up or expand their current Structural and TAVI services.

Do get in touch if you would like a copy of this. Thank you for your time.

Best wishes

Lauren MacPhee-Leech, on behalf of Valve for Life.

Lauren.MacPhee-Leech@ouh.nhs.uk